Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-001180-65Phase 3Completed
Phase 3, randomised, double-blind trial of neomycin sulfate + polymyxin B sulfate + gramicidin in external otitis (2 arms), sponsored by Alcon Inc. Primary endpoints: Efficacy outcome and Safety outcome. Started Sep 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-001180-65.